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Biological Pathway Specificity in the Cell—Does Molecular
Diversity Matter?
Nils G. Walter
Biology arises from the crowded molecular environment of the cell, rendering it
a challenge to understand biological pathways based on the reductionist, low‐
concentration in vitro conditions generally employed for mechanistic studies.
Recent evidence suggests that low‐affinity interactions between cellular
biopolymers abound, with still poorly defined effects on the complex interaction
networks that lead to the emergent properties and plasticity of life. Mass‐action
considerations are used here to underscore that the sheer number of weak
interactions expected from the complex mixture of cellular components
significantly shapes biological pathway specificity. In particular, on‐pathway—
i.e., “functional”—become those interactions thermodynamically and kinetically
stable enough to survive the incessant onslaught of the many off‐pathway
(“nonfunctional”) interactions. Consequently, to better understand the mole-
cular biology of the cell a further paradigm shift is needed toward mechanistic
experimental and computational approaches that probe intracellular diversity
and complexity more directly. Also see the video abstract here https://youtu.be/
T19X_zYaBzg.
1. Introduction
Linus Pauling—the famed chemist, biochemist, peace
activist, author, educator, double Nobel laureate and cofoun-
der of fields as diverse as quantum chemistry and molecular
biology—noted that “biological specificity is the major
problem about understanding life,”[1] a statement that applies
both to organismal species and the specificity of molecular
pathways in the cell. In the wake of the human genome
project, advances in high‐throughput transcriptome and
proteome analysis are giving us rapidly expanding views of
the sheer multitude of biopolymers found in a cell all at once,
leading to major efforts to create comprehensive “cell atlas”
catalogues.[2–8] These advances raise the critical problem;
how does such a deluge of intracellular players lead to the
emergence of specific molecular pathways from the “noise”
of the billions of dynamic hetero‐bimo-
lecular interactions possible, most of
which would seemingly not contribute
to cell survival and reproduction?
The human mind is bound to think in
linear cause‐and‐effect paradigms since
many events in our everyday experience
appear to be the result of identifiable
causes. Consequently, the basic assign-
ment of functions to the many nonprotein
coding (or noncoding) RNAs discovered to
be encoded in our genome, for example, is
seen as tied to the unresolved question of
whether or not they participate in any
specific intracellular pathway, with the
expectation that their removal should lead
to identifiable phenotypic changes.[9,10]
Similarly, bioscience textbooks teach that
the specificity of, say, an enzyme is a direct
consequence of its molecular structure in
relation to only that of its specific substrate;
and that a metabolic pathway is a very
specific sequence of reactions linked
through a linear flux of interrelated substrates. While breaking
down biology into a linked series of simple cause‐and‐effect
relationships facilitates human comprehension, a single look at a
map of the main metabolic pathways in a cell reminds us that the
cellular reality is more complex (Figure 1).[11] This insight led to
the rise of holistic systems biology approaches aiming to
understand the complexity of biology based on the notion that
cellular networks interact in synergistic ways that make the
whole more than the sum of its parts. As Noble,[12] one of the
recognized “godfathers” of systems biology, writes: “This…is the
challenge that sequencing the genome has raised. Can we put
Humpty‐Dumpty back together again? That is where ‘systems
biology’ comes in [a new approach that] is about putting together
rather than taking apart, integration rather than reduction.”
It is also increasingly appreciated that biology features a
pervasive element of stochasticity, leading to diverse,
spatiotemporally inhomogeneous distributions of molecules
both within and across individual cells, even when members
of a clonal cell line or tumor.[14–18] Yet, this growing
appreciation of the nonlinearity and stochasticity that drive
and distinguish biological systems has so far arguably not
influenced as much our understanding of what makes the
cell “pick and choose,” or evolve, specific metabolic, signal-
ing, or other pathways.
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integrating our classical knowledge from reductionist studies of
the pairwise binding interactions of purified biopolymers in
vitro with the emerging picture of the cell’s complex, crowded
molecular environment. Simple considerations based on the
law of mass action underscore that the plethora of diverse, weak
(“nonspecific”) interaction partners will have a significant
impact on any specific intermolecular complex in the cell.
Increasingly utilizing the cell itself as the reaction vessel of
choice for mechanistic studies therefore promises to yield a
refined biological specificity paradigm deeply dependent on
cellular context and the full diversity of all molecular interac-
tions, both strong and weak. Notably, rather than seeking to
provide a comprehensive review of biology, the current essay
aims to connect ideas and provoke new thought.
2. The Reductionist Law of Mass
Action, Expanded
When a natural law is first described in 1864,[19] forgotten, then
rediscovered in 1877 by the famous Henry van’t Hoff,[20] and
remains accepted over a century‐and‐a‐half later, it has to be
called foundational. The law of mass action predicts the
behavior of a chemical reaction in a dynamic equilibrium, in
that the ratio of the concentrations of products divided by those
of the reactants is constant for a given temperature and
pressure:
+ ⇔ +For a reaction of the stoichoimetry: aA bB cC dD
(1)
[ ] × [ ]
[ ] × [ ]The equilibrium constant K is:
C D
A B
c d
a b
(2)
Importantly, Waage and Guldberg[19] in 1864 already
recognized that a chemical equilibrium is dynamic such that
the ratio of the rate constant of the forward reaction divided by
that of the reverse reaction equals the equilibrium constant:[19]
=K k
k
forward
reverse
(3)
This observation gives rise to Le Chatelier’s principle whereby a
system at equilibrium that is subjected to a change in concentration,
temperature, or pressure readjusts to counteract the effect of the
applied change until a new equilibrium is established. Strikingly,
while not without exceptions at short time scales,[21] Le Chatelier’s
principle has found applications in fields as diverse as economy[22]
and mechanical engineering (per Newton’s third law: “For every
Figure 1. The generic biochemical pathway map of the cell. Reproduced with permission.[13] Copyright 2018/2019, F. Hoffmann‐La Roche Ltd. For a
detailed, interactive version of this map see ref. [13]
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action, there is an equal and opposite reaction”) in that a system
exposed to stress will generally respond by reducing that stress.
Such dynamic adaptation is also one key to understanding
biological specificity.
Suppose a cell contains two binding partners S and L of a
complex (such as two proteins, a protein and an RNA or DNA, or
two RNAs) at the typically low intracellular concentrations of
picomolar (for DNA in a mammalian cell) to micromolar (for a
highly expressed particle such as the ribosome), with their
dissociation equilibrium constant Kd,S having evolved to be similar
to the concentration of the limiting binding partner, say L. Then,
the limiting component L will have a 50% probability to be in
complex with its excess binding partner S at any given time.
Suppose further that a second binding partner C of dissociation
equilibrium constant Kd,C that coincidentally has the same value
as Kd,S now becomes expressed to the same cellular concentration
as S. It follows that through the ensuing two equilibria, which are
coupled by sharing L, S and C are effectively competing for L such
that each occupies L ≈ 33% of the time:
+ ⇔
= [ ] × [ ]K
S L SL leads to an equilibrium association
constant of:
S L
SL
d,S (4)
+ ⇔
[ ] × [ ]
[ ]
C L CL leads to an equilibrium association
constant of:
C L
CL
(5)
Together, these coupled equilibria lead to the relation:
/ = ([ ]×[ ])/([ ]×[ ])K K S CL S CLd,S d,C , which in our example of
Kd,S= Kd,C equals 1; and with [S]= [C] and [CL]+ [SL]+ [L]=
[L]total follows [CL]= [SL]= [L].
Now, suppose that S is significantly more specific for binding
L than competitor C, manifested in its Kd,S being 1000‐fold
tighter (i.e., smaller) than that of C, termed Kd,C. Yet, if C were
either found at 1000‐fold higher cellular concentration than S,
or there existed 1000 different forms of competitor C (C1, C2,
C3, …), each at the same low concentration of S, then we would
end up with the same scenario of L being occupied by the
specific binding partner S only 33% of the time, rather than
50%. That is, based on competition with a plethora of weak
binders, the law of mass action—in the form of a set of coupled
molecular equilibria—predicts that the concentration of a target
available to a tight binder is lowered, shifting the equilibrium
per Le Chatelier away from high‐specificity binding
(Figure 2A,B). Importantly, these fundamental considerations
are similarly at work in a more complex and realistic scenario
where the concentrations and affinities of the participating
components are more diverse than assumed in the above back‐
of‐the‐envelope example.
3. The Cell’s Reality Is Diversely Crowded
The predicted significant impact of a large number of low‐
affinity competitors on specific binding interactions is the
reality of the cell’s crowded molecular environment (Figure 2C).
In fact, increasing evidence is emerging that, for example, many
cryptic RNA‐binding sites exist on proteins of all trades,
including many metabolic housekeeping enzymes.[3,23,24] Simi-
larly, such dynamic equilibrium considerations are the essence
of recent modeling efforts of the regulatory RNA silencing
machinery, whereby each RNA target competes both for protein
partners of the RNA‐induced silencing complex (RISC) and
microRNAs (miRNAs; Figure 3).[25–27] This competition can
lead to some nonintuitive behaviors, such as that highly
Figure 2. The consequences of competition among a plethora of cellular
components. Reversible equilibrium binding of a high‐affinity (top) and
low‐affinity (bottom) partner to a biopolymer of interest A) becomes
shifted by Le Chatelier toward the low‐affinity binder when that is at
comparably high concentration B). C) In the crowded molecular en-
vironment of cell, this shift if even more significant due to the high
number of diverse, weak competitors.
Figure 3. Known examples for equilibrium binding competition affecting
biological function. During RNA silencing A), an activated RISC (dark
blue oval) recognizes an MRE (cyan rectangle) on an mRNA to down-
regulate its expression (red arrow). Upon expression of a significant
concentration of an mRNA with an MRE of higher affinity (dark blue
rectangle), or of a circular RNA with multiple MREs, a targeted mRNA
will seemingly be upregulated (green arrow) due to the shifting coupled
equilibrium siphoning off the limiting RISC B). MRE, miRNA response
element.
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expressed miRNAs become sequestered and thus neutralized in
terms of their regulatory power by targets that “sponge” them
up, whereas competition between binding sites on different
RNAs can lead to regulatory crosstalk and even apparent
upregulation of targets (Figure 3B).[25,26] Importantly, the
severity of these effects depends on both the affinities of all
potential binding partners and the extent to which a specific
component(s) of a given pathway becomes limiting in
concentration, which the cell of course can control dynamically
through gene regulation. Notably, evolution will fine‐tune the
affinity and gene expression level of each cellular component
concomitantly, leading to highly complex networks of interac-
tions where all content of the cell is interconnected and some
components become particularly highly connected system
hubs. Spontaneous evolutionary events such as a gene
duplication or mutation in a binding interface will therefore
not only affect the immediate pathway in which a cellular
component is majorly involved, but also in any other strong or
weak interaction the component has the capacity to engage
within the cell. This is particularly true since the cell is only
(tens of) micrometers in size; barrier‐less molecular diffusion
from one end to the other is thus generally fast (subsecond time
scales) so that all cellular components can in principle
encounter each other continuously to realize all of these
network interactions.
But this picture raises the puzzling question; if crowding in a
small volume and a plethora of interactions of varying strength
render everything in a cell part of one large, interconnected
network, what then specifies cellular pathways? For one, our
linear cause‐and‐effect expectation bias arguably makes us
“find” pathways everywhere, while in reality networking aspects
are more pervasive than typically considered. Second, cells have
developed ways to suppress undesired interactions, for exam-
ple, by compartmentalization through barriers such as mem-
branes or separated liquid–liquid phases,[28–30] or by dynamic
(often reversible) post‐biosynthetic modifications of interaction
interfaces, i.e., post‐translational modifications of a protein,[31]
post‐transcriptional modifications of an RNA (the “epitran-
scriptome”),[28,32,33] or epigenetic modifications of a DNA.[34]
Such spatiotemporal organization helps shape the network into
“funnels” (or, mathematically, “attractors”) that the cell can
remodel on demand, essentially by modulating the active local
concentration of (potential) network interaction partners. Third,
and perhaps most importantly, biology (or evolution) fine‐tunes
the baseline affinities of active pathway components in order to
strengthen subsets of connectivities within the network so that
specific pathways arise from the “forest”; conversely, nonpro-
ductive interactions will be selected against.[35]
Yet, even well‐studied metabolic pathways have to be
amended and expanded regularly, with important implications
for normal physiology and diseases such as cancer.[36–39]
Similarly, recent studies have found that hundreds of proteins
and RNAs “moonlight,” in that they each participate in multiple
distinct biochemical pathways by using different parts of their
surfaces to interact with diverse binding partners.[3,23,24,40,41]
When even metabolic enzymes that are thought to “normally”
phosphorylate small metabolites equally function as protein
kinases and phosphorylate a variety of protein substrates to
regulate fundamental cellular functions,[42] it is no wonder that
cellular networks show much more redundancy and plasticity,
and are harder to therapeutically target, than expected from
simple linear cause‐and‐effect relationships.
4. Kinetic Proofreading, Partitioning,
and Trapping
If thermodynamics and the law of mass action represent the
“Yin” underlying biology, kinetics is the inseparable (and
sometimes contradictory) “Yang.” In fact, thermodynamics may
not be the most important force in biology because, per
Heraclitus of Ephesus, “Life is Flux” (or in Greek, “Panta
Rhei,” meaning that change is the only constant in life).[43]
Accordingly, systems biology uses dynamic flux balance
analysis as a mathematical approach to understand the flow
of metabolites through a metabolic reaction network.[44] Most
individual reactions within metabolic pathways are reversible
except for a few (near‐)irreversible steps that oftentimes occur
early in the pathway and are highly regulated (Figure 1).
Similarly, complex biological processes as diverse as messenger
RNA (mRNA) translation,[45–48] pre‐mRNA splicing,[49,50] nu-
cleotide excision repair of damaged DNA,[51] and discrimination
of self‐ and non‐self‐peptides by T cells[52] all rely on a mix of
sequential reversible and irreversible steps to effect what is
called “kinetic proofreading” (Figure 4). As the name implies,
this mechanism enhances biological specificity and fidelity
beyond the level that can ordinarily be achieved by the
difference in thermodynamic‐free energy between correct and
incorrect interactions.[53,54] In particular, the insertion of
energy‐consuming and therefore (near‐)irreversible (or unidir-
ectional) steps isolates the flanking reversible steps from one
another so that kinetic partitioning between moving forward
and instead going off‐path and disassembling the complex can
occur independently, both before and after the irreversible step
(Figure 4), thus in effect multiplying the two respective error
Figure 4. The basis of kinetic proofreading. An enzyme reversibly binds
its substrate that can be rejected (red arrow) or further accommodated
upon binding of a cofactor (green circle, “pawl”). Upon consumption of
energy through ATP hydrolysis or some other energetic process, the free
energy (ΔG) landscape changes in ways that allow for a (near‐)irrever-
sible step toward a new conformation or configuration, wherein another,
independent rejection step completes the proofreading (PF) against
non‐ or near‐cognate substrates. Only if the kinetics of the forward steps
exceed that of the rejection steps will the reaction be completed suc-
cessfully. ATP, adenosine triphosphate.
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frequencies for enhanced fidelity. In fact, even without
irreversible consumption of energy some level of “conforma-
tional proofreading” is achieved by a programmed structural
mismatch between two binding partners that have to strain (i.e.,
undergo an induced fit) to match each other perfectly.[55] For
example, the ribosome is thought to have evolved into an
optimal decoder by using the binding energy of an optimally
decoding transfer RNA for conformational distortions that
distinguish it from a multitude of near‐cognate substrates.[56]
Taken together, the cell is a cauldron churning far from
equilibrium where the “magic” of life emerges with the help of
energy‐consuming reactions that make certain steps kinetically
irreversible and so help specify the pathways currently favored
among the entire network. The network—like any “safety
net”—provides added stability and robustness in the face of
outside stress; yet it also enables dynamic system control
through feedback and feedforward loops[57] that lead to
“emergent” cellular behaviors that we identify as “life,”
including homeostasis, responsiveness, adaptation, growth,
reproduction, and heredity. Notably, if thermodynamics were
dominating, a low‐energy (stable) state would always end up
kinetically trapping each pathway, without (much) further
change. Instead, nature utilizes kinetic traps as “attractors”
along a pathway but then makes them shorter‐lived by utilizing
external energy (often in the form of nucleoside triphosphate
(NTP) hydrolysis, but also other chemical conversions) to (re)
move a trapping component (or “pawl”; Figure 4). The resulting
“biased Brownian ratchet machine” draws path directionality
from the random thermal fluctuations it constantly experiences
but then directionally “rectifies” or “biases” with the energy‐
consuming irreversible step.[50,58,59]
Specificity within biological pathways therefore has both
thermodynamic and kinetic drivers. In light of the onslaught of
competing nonspecific, weak interactions, on‐pathway‐specific
interactions will be those both thermodynamically sufficiently
stable and kinetically sufficiently long‐lived to survive and not
be discarded or proofread. Furthermore, since the kinetic
behavior of each single molecule in the cell is highly stochastic,
with the individual event onset (or wait) times often exponen-
tially distributed,[60] the order in which steps occur in a complex
pathway can sometimes vary, as was observed, for example,
during spliceosome assembly.[61] Such stochasticity results in
the coexistence of multiple parallel pathways, all productive,
and is one manifestation of so‐called “fuzzy logic” in biology,
where the binary all‐or‐none choice of computer logic is
replaced with partial truth values ranging from completely true
to completely false.[62,63]
5. Biological Specificity, Refined by Diverse
Cellular Interactions
Perhaps a quintessential example of the challenges associated with
transferring the concept of specificity from purified in vitro
systems to the cellular environment is the debate of Mg2+
homeostasis.[64,65] Only recently—late compared to the better
understood, chemically similar earth alkali metal ion Ca2+—has it
become clear that the cell actively maintains a high (millimolar)
Mg2+ concentration using specialized ion channels.[65,69–71] The
exact concentration of free Mg2+ in the cell is hotly debated and
varies with the KD of the detection probe, with this KD itself being
cell‐condition (pH, ionic strength, etc.) dependent, which has led
to varying estimates of the free Mg2+ concentration ranging
between 0.5mM and 2mM.[72] What sometimes seems forgotten,
however, is that a large fraction of the total ≈20mM Mg2+ in the
cell is bound by nucleic acids, especially RNA, since ≈90% of the
negatively charged phosphates are charge‐neutralized by Mg2+;[73]
similarly, each NTP typically chelates one Mg2+ ion.[74] Given its
rapid dissociation rate constant, the divalent ion therefore will
quickly equilibrate between many Mg2+‐binding sites in the cell
(Figure 3) so that a chelating detection probe is subject to
competition for binding of Mg2+, especially from those compe-
titors with a higher affinity for Mg2+ or a higher concentration
than the probe itself (Figure 2). An example is the recent
observation that amino acid chelated Mg2+ pools are readily
functional in promoting RNA folding and function.[75] What
fraction of Mg2+ is detected as “free” will therefore be extremely
sensitive to both the probe used and all diverse molecular species
present in the cell at the time, as well as the molecular
characteristics of their individual Mg2+ binding sites. It is no
wonder that much ambiguity arises from such measurements.
Another instructive example is that of transcription initiation
in the eukaryotic cell, a very dynamic process driven by
promoters, transcription factors, and distal enhancers.[76] These
elements jointly recruit RNA polymerase to initiate transcrip-
tion on specific start sites in a highly reversible assembly
process wherein transcription factors rapidly exchange between
possible binding sites; in effect, promoters are constantly
competing for both cofactors and RNA polymerase.[76] To
facilitate this process, many eukaryotic transcription factors
contain intrinsically disordered, so‐called low‐complexity do-
mains (LCD) that allow them to rapidly form local high‐
concentration hubs through dynamic, multivalent, specific
LCD–LCD interactions that recently have been visualized by
live‐cell single molecule imaging.[77,78] These observations are
an example of the rapidly expanding universe of functionally
important, dynamic liquid–liquid phase separation processes
that make cellular life more efficient by organizing it into
membrane‐less organelles of enhanced local concentra-
tion.[28–30] Transcription initiation is thus one exemplary
process where the cell both exploits and suppresses the law of
mass action inside and outside, respectively, of a condensed
liquid phase in dynamic fashion. Even more fundamentally, the
competition between strongly binding promoter sequences and
all other segments of a DNA weakly associating with an RNA
polymerase undoubtedly ensures that only highly cooperative,
multivalent transcription initiation complexes will result in
successful commitment to gene expression.[79] Similarly, it has
been shown that the empirically observed “Savageau demand
rules” that genes needed often tend to be regulated by
transcription activators, whereas genes rarely needed are more
often regulated by repressors, can be explained by the fact that
in both cases the activator or repressor site is occupied most of
the time, thus minimizing errors induced by weakly binding
competitors.[80,81]
Our considerations so far assumed effectively time‐invariant
pairwise interactions between binding or reaction partners,
modulated by direct competition with other pairwise
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interactions. An additional dimension often absent from or not
considered in purified biophysical systems are secondary effects
arising from higher‐order interactions. A classic example are
allosteric effects where the binding of one interaction partner
modulates the binding affinity toward another partner, and vice
versa, such as allosteric activation or inhibition of a protein
enzyme.[82,83] For biological machines such as the ribosome[84]
or the spliceosome[85] such allosteric effects are known to
facilitate an ordered assembly and reaction process. And yet,
they are significantly beyond simple cause‐and‐effect relation-
ships, with thousands of different molecules in a cell
undoubtedly having a plethora of allosteric effects on each
other that still await discovery, further increasing interconnec-
tivity and plasticity. Given their transient nature and unknown
functional consequences, we probably will still need to develop
entirely new screening tools to be able to map these dynamic
interconnections in their entirety.
6. Outlook and Call for Action
As we continue to peer deeper and deeper into the cauldron of
cellular life we are starting to understand more of its
sophisticated spatiotemporal organization where the real estate
agents’ mantra of “location, location, location” is critical,[86] yet
of course is only a consequence of specific “interactions,
interactions, interactions.” Understanding the specificity of
these interactions is at the heart of deciphering the deeper
“code of life,”[87] a challenge that runs counter to human
intuition but deserves our full attention. To meet this challenge,
we need to acknowledge the fact that, just as in societal life,
diversity (in affinity and concentration) matters since it
profoundly shapes biomolecular specificity in often unexpected
ways by enhancing competition. And just as in modern
societies, diversity in biology creates both challenges and
opportunities. Recent progress in moving biophysical inquiries
into the cell[16,88,89] gives hope that we are at the beginning of
truly unearthing the foundations of biology. More tools for
direct intracellular probing of biological pathways still need to
be developed, including—but not limited to—improved (high-
er‐contrast, higher‐resolution, more versatile) fluorescent and
other minimally invasive imaging probes, more in‐cell manip-
ulation tools (such as genome editing and synthetic biology
circuitry), elegant ways to combine biochemical fractionation of
cellular components with tagging (barcoding) their spatiotem-
poral origins in the cell, multiplexed and high‐throughput
molecular characterization tools for cellular components
probed in situ, and more powerful systems biology tools to
simulate ever more complex interaction networks. As always,
new tools will undoubtedly become drivers for discovering new
biology, ultimately solving the question of how biological
pathways breathe life into a cell.
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